Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Major Depressive Disorder - MDD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05503966
What this trial is testing

Combining Antidepressants and Attention Bias Modification in Depression

Who this might be right for
Depressive Disorder
University of Oslo 246
Large-scale testing (Phase 3)Ended earlyNCT00637494
What this trial is testing

Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Who this might be right for
Psychotic DepressionSevere Major Depression With Psychotic FeaturesPsychosis
Corcept Therapeutics 292
Post-approval studies (Phase 4)UnknownNCT00335205
What this trial is testing

A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.

Who this might be right for
Bipolar DisorderMajor Depressive Disorder
Sheba Medical Center 60
Not applicableStudy completedNCT00609453
What this trial is testing

Brain Imaging of Psychotherapy for Depression

Who this might be right for
Major Depressive Disorder
University of North Carolina, Chapel Hill 27
Post-approval studies (Phase 4)Study completedNCT01000805
What this trial is testing

Duloxetine in Major Depressive Disorder (MDD) and Associated Painful Symptoms

Who this might be right for
Major Depressive Disorder
Eli Lilly and Company 528
Not applicableStudy completedNCT01710202
What this trial is testing

Sensitivity of Short and Long Allele Carriers of the 5-HTTLPR to Environmental Threat Post Hydrocortisone Administration

Who this might be right for
Major Depressive DisorderAnxiety Disorders
University of Texas at Austin 120
Early research (Phase 1)Study completedNCT06570369
What this trial is testing

Explore the Effect of SP-624 on Brain Network Analytics in Healthy Adults and Adults With Major Depression

Who this might be right for
Major Depressive DisorderDepressionHealthy
Sirtsei Pharmaceuticals, Inc. 26
Not applicableStudy completedNCT07526454
What this trial is testing

Electroconvulsive Therapy Versus Intravenous Ketamine in Treatment-Resistant Major Depressive Disorder

Who this might be right for
Electroconvulsive TherapyIntravenous KetamineTreatment-Resistant+1 more
Tanta University 70
Testing effectiveness (Phase 2)Study completedNCT02459236
What this trial is testing

Intermittent Doses of CERC-301 in MDD

Who this might be right for
Major Depressive Disorder
Avalo Therapeutics, Inc. 115
Early research (Phase 1)Study completedNCT01263236
What this trial is testing

LY2940094 in Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
BlackThorn Therapeutics, Inc. 66
Testing effectiveness (Phase 2)Study completedNCT06558344
What this trial is testing

Test Different Doses of BI 1569912 in People With Depression

Who this might be right for
Depressive Disorder, Major
Boehringer Ingelheim 225
Early research (Phase 1)Study completedNCT03142919
What this trial is testing

Lipopolysaccharide (LPS) Challenge in Depression

Who this might be right for
Major Depressive Disorder
Laureate Institute for Brain Research, Inc. 64
Large-scale testing (Phase 3)Ended earlyNCT01123707
What this trial is testing

To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder (MDD)
Otsuka Pharmaceutical Development & Commercialization, Inc. 173
Large-scale testing (Phase 3)Study completedNCT04345471
What this trial is testing

MD-120 in Patients With Depression

Who this might be right for
Major Depressive Disorder
Mochida Pharmaceutical Company, Ltd. 615
Testing effectiveness (Phase 2)WithdrawnNCT04410341
What this trial is testing

The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder Patients

Who this might be right for
Major Depressive Disorder
Sadat City University
Not applicableStudy completedNCT02385786
What this trial is testing

Mindfulness-Based Cognitive Therapy Effect on Depression and C-Reactive Protein Levels After 8 Weeks of Treatment

Who this might be right for
Major Depressive Disorder
University of California, San Francisco 43
Large-scale testing (Phase 3)Study completedNCT00048607
What this trial is testing

Treatment of Patients With Major Depressive Disorder With MK0869 (0869-062)(COMPLETED)

Who this might be right for
Major Depressive Disorder
Merck Sharp & Dohme LLC 600
Testing effectiveness (Phase 2)Looking for participantsNCT05570812
What this trial is testing

Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV

Who this might be right for
Major Depressive DisorderAnxiety DepressionHIV
Massachusetts General Hospital 120
Not applicableStudy completedNCT07061600
What this trial is testing

Enhancing Depression Literacy and Reducing Stigma in Adolescents Through Social Media

Who this might be right for
Depressive DisorderDepression - Major Depressive DisorderDepression in Adolescence
Ludwig-Maximilians - University of Munich 170
Post-approval studies (Phase 4)Study completedNCT02544607
What this trial is testing

Ketamine for Depression: An MRI Study

Who this might be right for
DepressionAnxious DepressionMajor Depressive Disorder
Massachusetts General Hospital 25
Next Page